-
Uncategorized6 months ago
Layoffs at Novo’s Ex-Catalent Site Despite Signs of Turnaround, Continued Investment
Layoffs at Novo’s Ex-Catalent Site Despite Signs of Turnaround, Continued Investment
-
Uncategorized6 months agoFDA approves Lilly obesity pill, triggering battle with Novo Nordisk
Foundayo could erase the Wegovy pill’s four-month head start as the two drugmakers clash on a debate of efficacy and convenience.
-
Uncategorized6 months agoSpatial Biology
Spatial biology is a rapidly advancing discipline that examines biological molecules (such as DNA, RNA, and proteins) within their native locations in tissues. This approach offers...
-
Uncategorized6 months ago
Novo cuts 400 jobs in Indiana as Scholar Rock refiles drug linked to the factory
Novo cuts 400 jobs in Indiana as Scholar Rock refiles drug linked to the factory
-
Uncategorized6 months ago
Text Mining Culture Conditions and Glycosylation Relationships
A novel data gathering approach that relies on “text mining” can help process developers better understand the complex relationships between culture conditions and glycosylation, say the...
-
Uncategorized6 months agoEli Lilly’s obesity pill approved by FDA, setting up fierce competition with Novo Nordisk
Eli Lilly’s obesity pill was approved by the Food and Drug Administration on Wednesday, setting it up for fierce competition against Novo Nordisk’s new Wegovy pill...
-
Uncategorized6 months ago
Lilly wins approval of anti-obesity pill orforglipron, setting up new battle with Novo
Lilly wins approval of anti-obesity pill orforglipron, setting up new battle with Novo
-
Uncategorized6 months ago
How a 20-year old asthma drug is boosting food allergy research
How a 20-year old asthma drug is boosting food allergy research
-
Uncategorized6 months ago
Can AI Agents Automate Scientific Discovery?
Nvidia CEO Jensen Huang asserts that agentic AI systems are driving innovation across industries. At his annual NVIDIA GTC keynote, Huang highlighted OpenClaw, the personal AI...
-
Uncategorized6 months agoSTAT+: Insilico Medicine CEO on how best to use AI in drug development
You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in...
FDA warning letter accuses Bausch & Lomb of lacking commitment to remediation
Deep dive: Psychedelics back on FDA’s doorstep
‘Patients are not a renewable resource’: Rethinking rare disease R&D
Scientists turn pig semen extract into eye drops that kill cancer in mice
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
